Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 2000 Sep 1;350(Pt 2):555–561.

Multidrug resistance protein MRP1 protects against the toxicity of the major lipid peroxidation product 4-hydroxynonenal.

J Renes 1, E E de Vries 1, G J Hooiveld 1, I Krikken 1, P L Jansen 1, M Müller 1
PMCID: PMC1221284  PMID: 10947971

Abstract

4-Hydroxynonenal (4HNE) is the most prevalent toxic lipid peroxidation product formed during oxidative stress. It exerts its cytotoxicity mainly by the modification of intracellular proteins. The detection of 4HNE-modified proteins in several degenerative disorders suggests a role for 4HNE in the onset of these diseases. Efficient protection mechanisms are required to prevent the intracellular accumulation of 4HNE. The toxicity of 4HNE was tested with the small cell lung cancer cell lines GLC(4) and the multidrug-resistance-protein (MRP1)-overexpressing counterpart GLC(4)/Adr. In the presence of the MRP1 inhibitor MK571 or the GSH-depleting agent buthionine sulphoximine, both cell lines became more sensitive and showed decreased survival. Transport experiments were performed with the (3)H-labelled glutathione S-conjugate of 4HNE ([(3)H]GS-4HNE) with membrane vesicles from GLC(4)-derived cell lines with different expression levels of MRP1. [(3)H]GS-4HNE was taken up in an ATP-dependent manner and the transport rate was dependent on the amount of MRP1. The MRP1 inhibitor MK571 decreased [(3)H]GS-4HNE uptake. MRP1-specific [(3)H]GS-4HNE transport was demonstrated with membrane vesicles from High Five insect cells overexpressing recombinant MRP1. Kinetic experiments showed an apparent K(m) of 1.6+/-0.21 microM (mean+/-S.D.) for MRP1-mediated [(3)H]GS-4HNE transport. In conclusion, MRP1 has a role in the protection against 4HNE toxicity and GS-4HNE is a novel MRP1 substrate. MRP1, together with GSH, is hypothesized to have a role in the defence against oxidative stress.

Full Text

The Full Text of this article is available as a PDF (142.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Askelöf P., Guthenberg C., Jakobson I., Mannervik B. Purification and characterization of two glutathione S-aryltransferase activities from rat liver. Biochem J. 1975 Jun;147(3):513–522. doi: 10.1042/bj1470513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Boon P. J., Marinho H. S., Oosting R., Mulder G. J. Glutathione conjugation of 4-hydroxy-trans-2,3-nonenal in the rat in vivo, the isolated perfused liver and erythrocytes. Toxicol Appl Pharmacol. 1999 Sep 15;159(3):214–223. doi: 10.1006/taap.1999.8742. [DOI] [PubMed] [Google Scholar]
  3. Borst P., Evers R., Kool M., Wijnholds J. The multidrug resistance protein family. Biochim Biophys Acta. 1999 Dec 6;1461(2):347–357. doi: 10.1016/s0005-2736(99)00167-4. [DOI] [PubMed] [Google Scholar]
  4. Chung F. L., Nath R. G., Ocando J., Nishikawa A., Zhang L. Deoxyguanosine adducts of t-4-hydroxy-2-nonenal are endogenous DNA lesions in rodents and humans: detection and potential sources. Cancer Res. 2000 Mar 15;60(6):1507–1511. [PubMed] [Google Scholar]
  5. Cole S. P., Bhardwaj G., Gerlach J. H., Mackie J. E., Grant C. E., Almquist K. C., Stewart A. J., Kurz E. U., Duncan A. M., Deeley R. G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science. 1992 Dec 4;258(5088):1650–1654. doi: 10.1126/science.1360704. [DOI] [PubMed] [Google Scholar]
  6. Cole S. P., Deeley R. G. Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP. Bioessays. 1998 Nov;20(11):931–940. doi: 10.1002/(SICI)1521-1878(199811)20:11<931::AID-BIES8>3.0.CO;2-J. [DOI] [PubMed] [Google Scholar]
  7. Danielson U. H., Esterbauer H., Mannervik B. Structure-activity relationships of 4-hydroxyalkenals in the conjugation catalysed by mammalian glutathione transferases. Biochem J. 1987 Nov 1;247(3):707–713. doi: 10.1042/bj2470707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Eckl P. M., Ortner A., Esterbauer H. Genotoxic properties of 4-hydroxyalkenals and analogous aldehydes. Mutat Res. 1993 Dec;290(2):183–192. doi: 10.1016/0027-5107(93)90158-c. [DOI] [PubMed] [Google Scholar]
  9. Esterbauer H., Schaur R. J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med. 1991;11(1):81–128. doi: 10.1016/0891-5849(91)90192-6. [DOI] [PubMed] [Google Scholar]
  10. Evers R., Cnubben N. H., Wijnholds J., van Deemter L., van Bladeren P. J., Borst P. Transport of glutathione prostaglandin A conjugates by the multidrug resistance protein 1. FEBS Lett. 1997 Dec 8;419(1):112–116. doi: 10.1016/s0014-5793(97)01442-7. [DOI] [PubMed] [Google Scholar]
  11. Flens M. J., Zaman G. J., van der Valk P., Izquierdo M. A., Schroeijers A. B., Scheffer G. L., van der Groep P., de Haas M., Meijer C. J., Scheper R. J. Tissue distribution of the multidrug resistance protein. Am J Pathol. 1996 Apr;148(4):1237–1247. [PMC free article] [PubMed] [Google Scholar]
  12. Gao M., Loe D. W., Grant C. E., Cole S. P., Deeley R. G. Reconstitution of ATP-dependent leukotriene C4 transport by Co-expression of both half-molecules of human multidrug resistance protein in insect cells. J Biol Chem. 1996 Nov 1;271(44):27782–27787. doi: 10.1074/jbc.271.44.27782. [DOI] [PubMed] [Google Scholar]
  13. Girotti A. W. Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res. 1998 Aug;39(8):1529–1542. [PubMed] [Google Scholar]
  14. Gorospe M., Liu Y., Xu Q., Chrest F. J., Holbrook N. J. Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human breast carcinoma cells by prostaglandin A2. Mol Cell Biol. 1996 Mar;16(3):762–770. doi: 10.1128/mcb.16.3.762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Grant C. E., Valdimarsson G., Hipfner D. R., Almquist K. C., Cole S. P., Deeley R. G. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res. 1994 Jan 15;54(2):357–361. [PubMed] [Google Scholar]
  16. Grune T., Siems W. G., Petras T. Identification of metabolic pathways of the lipid peroxidation product 4-hydroxynonenal in in situ perfused rat kidney. J Lipid Res. 1997 Aug;38(8):1660–1665. [PubMed] [Google Scholar]
  17. Hay D. W., Torphy T. J., Undem B. J. Cysteinyl leukotrienes in asthma: old mediators up to new tricks. Trends Pharmacol Sci. 1995 Sep;16(9):304–309. doi: 10.1016/s0165-6147(00)89059-8. [DOI] [PubMed] [Google Scholar]
  18. Hayes J. D., McLellan L. I. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic Res. 1999 Oct;31(4):273–300. doi: 10.1080/10715769900300851. [DOI] [PubMed] [Google Scholar]
  19. Hayes J. D., Pulford D. J., Ellis E. M., McLeod R., James R. F., Seidegård J., Mosialou E., Jernström B., Neal G. E. Regulation of rat glutathione S-transferase A5 by cancer chemopreventive agents: mechanisms of inducible resistance to aflatoxin B1. Chem Biol Interact. 1998 Apr 24;111-112:51–67. doi: 10.1016/s0009-2797(97)00151-8. [DOI] [PubMed] [Google Scholar]
  20. He N. G., Singhal S. S., Srivastava S. K., Zimniak P., Awasthi Y. C., Awasthi S. Transfection of a 4-hydroxynonenal metabolizing glutathione S-transferase isozyme, mouse GSTA4-4, confers doxorubicin resistance to Chinese hamster ovary cells. Arch Biochem Biophys. 1996 Sep 1;333(1):214–220. doi: 10.1006/abbi.1996.0383. [DOI] [PubMed] [Google Scholar]
  21. Hipfner D. R., Deeley R. G., Cole S. P. Structural, mechanistic and clinical aspects of MRP1. Biochim Biophys Acta. 1999 Dec 6;1461(2):359–376. doi: 10.1016/s0005-2736(99)00168-6. [DOI] [PubMed] [Google Scholar]
  22. Hubatsch I., Ridderström M., Mannervik B. Human glutathione transferase A4-4: an alpha class enzyme with high catalytic efficiency in the conjugation of 4-hydroxynonenal and other genotoxic products of lipid peroxidation. Biochem J. 1998 Feb 15;330(Pt 1):175–179. doi: 10.1042/bj3300175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Ishikawa T., Esterbauer H., Sies H. Role of cardiac glutathione transferase and of the glutathione S-conjugate export system in biotransformation of 4-hydroxynonenal in the heart. J Biol Chem. 1986 Feb 5;261(4):1576–1581. [PubMed] [Google Scholar]
  24. Kim I. K., Lee J. H., Sohn H. W., Kim H. S., Kim S. H. Prostaglandin A2 and delta 12-prostaglandin J2 induce apoptosis in L1210 cells. FEBS Lett. 1993 Apr 26;321(2-3):209–214. doi: 10.1016/0014-5793(93)80110-g. [DOI] [PubMed] [Google Scholar]
  25. König J., Nies A. T., Cui Y., Leier I., Keppler D. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim Biophys Acta. 1999 Dec 6;1461(2):377–394. doi: 10.1016/s0005-2736(99)00169-8. [DOI] [PubMed] [Google Scholar]
  26. Laurent A., Alary J., Debrauwer L., Cravedi J. P. Analysis in the rat of 4-hydroxynonenal metabolites excreted in bile: evidence of enterohepatic circulation of these byproducts of lipid peroxidation. Chem Res Toxicol. 1999 Oct;12(10):887–894. doi: 10.1021/tx9900425. [DOI] [PubMed] [Google Scholar]
  27. Leier I., Jedlitschky G., Buchholz U., Center M., Cole S. P., Deeley R. G., Keppler D. ATP-dependent glutathione disulphide transport mediated by the MRP gene-encoded conjugate export pump. Biochem J. 1996 Mar 1;314(Pt 2):433–437. doi: 10.1042/bj3140433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Liu W., Akhand A. A., Kato M., Yokoyama I., Miyata T., Kurokawa K., Uchida K., Nakashima I. 4-hydroxynonenal triggers an epidermal growth factor receptor-linked signal pathway for growth inhibition. J Cell Sci. 1999 Jul;112(Pt 14):2409–2417. doi: 10.1242/jcs.112.14.2409. [DOI] [PubMed] [Google Scholar]
  29. Luo X., Pitkänen S., Kassovska-Bratinova S., Robinson B. H., Lehotay D. C. Excessive formation of hydroxyl radicals and aldehydic lipid peroxidation products in cultured skin fibroblasts from patients with complex I deficiency. J Clin Invest. 1997 Jun 15;99(12):2877–2882. doi: 10.1172/JCI119481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Mattson M. P. Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity. Trends Neurosci. 1998 Feb;21(2):53–57. doi: 10.1016/s0166-2236(97)01188-0. [DOI] [PubMed] [Google Scholar]
  31. Müller M., Meijer C., Zaman G. J., Borst P., Scheper R. J., Mulder N. H., de Vries E. G., Jansen P. L. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):13033–13037. doi: 10.1073/pnas.91.26.13033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Müller M., Roelofsen H., Jansen P. L. Secretion of organic anions by hepatocytes: involvement of homologues of the multidrug resistance protein. Semin Liver Dis. 1996 May;16(2):211–220. doi: 10.1055/s-2007-1007233. [DOI] [PubMed] [Google Scholar]
  33. O'connor T., Ireland L. S., Harrison D. J., Hayes J. D. Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members. Biochem J. 1999 Oct 15;343(Pt 2):487–504. [PMC free article] [PubMed] [Google Scholar]
  34. Ollinger K., Brunmark A. Effect of different oxygen pressures and N,N'-diphenyl-p-phenylenediamine on Adriamycin toxicity to cultured neonatal rat heart myocytes. Biochem Pharmacol. 1994 Nov 1;48(9):1707–1715. doi: 10.1016/0006-2952(94)90455-3. [DOI] [PubMed] [Google Scholar]
  35. Page S., Fischer C., Baumgartner B., Haas M., Kreusel U., Loidl G., Hayn M., Ziegler-Heitbrock H. W., Neumeier D., Brand K. 4-Hydroxynonenal prevents NF-kappaB activation and tumor necrosis factor expression by inhibiting IkappaB phosphorylation and subsequent proteolysis. J Biol Chem. 1999 Apr 23;274(17):11611–11618. doi: 10.1074/jbc.274.17.11611. [DOI] [PubMed] [Google Scholar]
  36. Paradis V., Kollinger M., Fabre M., Holstege A., Poynard T., Bedossa P. In situ detection of lipid peroxidation by-products in chronic liver diseases. Hepatology. 1997 Jul;26(1):135–142. doi: 10.1053/jhep.1997.v26.pm0009214462. [DOI] [PubMed] [Google Scholar]
  37. Renes J., de Vries E. G., Nienhuis E. F., Jansen P. L., Müller M. ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1. Br J Pharmacol. 1999 Feb;126(3):681–688. doi: 10.1038/sj.bjp.0702360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Sayre L. M., Zelasko D. A., Harris P. L., Perry G., Salomon R. G., Smith M. A. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem. 1997 May;68(5):2092–2097. doi: 10.1046/j.1471-4159.1997.68052092.x. [DOI] [PubMed] [Google Scholar]
  39. Selley M. L., Bourne D. J., Bartlett M. R., Tymms K. E., Brook A. S., Duffield A. M., Ardlie N. G. Occurrence of (E)-4-hydroxy-2-nonenal in plasma and synovial fluid of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis. 1992 Apr;51(4):481–484. doi: 10.1136/ard.51.4.481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Spitz D. R., Sullivan S. J., Malcolm R. R., Roberts R. J. Glutathione dependent metabolism and detoxification of 4-hydroxy-2-nonenal. Free Radic Biol Med. 1991;11(4):415–423. doi: 10.1016/0891-5849(91)90159-z. [DOI] [PubMed] [Google Scholar]
  41. Srivastava S., Chandra A., Wang L. F., Seifert W. E., Jr, DaGue B. B., Ansari N. H., Srivastava S. K., Bhatnagar A. Metabolism of the lipid peroxidation product, 4-hydroxy-trans-2-nonenal, in isolated perfused rat heart. J Biol Chem. 1998 May 1;273(18):10893–10900. doi: 10.1074/jbc.273.18.10893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Toyokuni S., Uchida K., Okamoto K., Hattori-Nakakuki Y., Hiai H., Stadtman E. R. Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2616–2620. doi: 10.1073/pnas.91.7.2616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Uchida K., Shiraishi M., Naito Y., Torii Y., Nakamura Y., Osawa T. Activation of stress signaling pathways by the end product of lipid peroxidation. 4-hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. J Biol Chem. 1999 Jan 22;274(4):2234–2242. doi: 10.1074/jbc.274.4.2234. [DOI] [PubMed] [Google Scholar]
  44. Uchida K., Szweda L. I., Chae H. Z., Stadtman E. R. Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8742–8746. doi: 10.1073/pnas.90.18.8742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Versantvoort C. H., Broxterman H. J., Bagrij T., Scheper R. J., Twentyman P. R. Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein. Br J Cancer. 1995 Jul;72(1):82–89. doi: 10.1038/bjc.1995.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Versantvoort C. H., Withoff S., Broxterman H. J., Kuiper C. M., Scheper R. J., Mulder N. H., de Vries E. G. Resistance-associated factors in human small-cell lung-carcinoma GLC4 sub-lines with increasing adriamycin resistance. Int J Cancer. 1995 May 4;61(3):375–380. doi: 10.1002/ijc.2910610317. [DOI] [PubMed] [Google Scholar]
  47. Wang W., Ballatori N. Endogenous glutathione conjugates: occurrence and biological functions. Pharmacol Rev. 1998 Sep;50(3):335–356. [PubMed] [Google Scholar]
  48. Yamane Y., Furuichi M., Song R., Van N. T., Mulcahy R. T., Ishikawa T., Kuo M. T. Expression of multidrug resistance protein/GS-X pump and gamma-glutamylcysteine synthetase genes is regulated by oxidative stress. J Biol Chem. 1998 Nov 20;273(47):31075–31085. doi: 10.1074/jbc.273.47.31075. [DOI] [PubMed] [Google Scholar]
  49. Ylä-Herttuala S., Palinski W., Rosenfeld M. E., Parthasarathy S., Carew T. E., Butler S., Witztum J. L., Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest. 1989 Oct;84(4):1086–1095. doi: 10.1172/JCI114271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Yoritaka A., Hattori N., Uchida K., Tanaka M., Stadtman E. R., Mizuno Y. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):2696–2701. doi: 10.1073/pnas.93.7.2696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Zaman G. J., Lankelma J., van Tellingen O., Beijnen J., Dekker H., Paulusma C., Oude Elferink R. P., Baas F., Borst P. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7690–7694. doi: 10.1073/pnas.92.17.7690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Zijlstra J. G., de Vries E. G., Mulder N. H. Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res. 1987 Apr 1;47(7):1780–1784. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES